Latest News

Very low-dose Avastin effective for preventing blindness in preterm infants



Babies born prematurely who require treatment to prevent blindness from retinopathy of prematurity (ROP) could be treated with a dose of Avastin (bevacizumab) that is a fraction of the dose commonly used for ROP currently. Results from the dose-finding study were published April 23 in JAMA Ophthalmology. The study was conducted by the Pediatric Eye Disease Investigator Group (PEDIG) and supported by the National Eye Institute (NEI), part of the National Institutes of Health.

Source link

Related posts

Five Prime Therapeutics Announces Resignation of Dr. Lewis T. “Rusty” Williams From Board of Directors

Newsemia

How Should We Move Earth From Orbit And Spare Humanity From Doomsday?

Newsemia

Medical News Today: What to know about cataract surgery

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World